Abstract: A controller of an atomic system controls operation of potential sources to cause potential generating signals to be provided. Application of the potential generating signals to respective potential generating elements causes performance of a split operation causing confinement of a first subset of atomic objects of an object crystal in a first potential well and a second subset of atomic objects of the object crystal in a second potential well. The first subset consists of one or more atomic objects. The object crystal includes atomic objects of at least two species. The controller controls operation of manipulation sources to cause manipulation signals to be incident on the first subset. The controller receives a sensor signal generated by a photodetector configured to capture fluorescence signals generated by the first subset. The controller processes the sensor signal to determine a respective species of at least one atomic object of the first subset.

Abstract: A method for laser cooling an object crystal comprising at least two atomic objects and confined by a confinement apparatus is provided. A controller controls one or more manipulation sources to cause a first instance of manipulation signals to be incident on the object crystal at a target location defined at least in part by the confinement apparatus. The manipulation signals are configured to laser cool a first motional mode of the object crystal. The controller causes an adiabatic transfer of phonons from a second motional mode of the object crystal to the first motional mode of the object crystal. The controller controls the one or more manipulation sources to cause a second instance of the manipulation signals to be incident on the object crystal at the target location. The manipulation signals are configured to laser cool the first motional mode of the object crystal.

Abstract: A rear sight assembly is disclosed. The rear sight assembly contains a housing defining a first opening, a second opening, and a third opening, a rear sight mechanism containing a thumb wheel positioned in the first opening, at least partially threaded support member positioned in the second opening and the third opening, wherein the at least partially threaded support member is threaded through the thumb wheel, and a rear aiming point member adjustably coupled with the at least partially threaded support member.

Abstract: A rear sight assembly is disclosed. The rear sight assembly contains a housing defining a first opening, a second opening, and a third opening, a rear sight mechanism containing a thumb wheel positioned in the first opening, at least partially threaded support member positioned in the second opening and the third opening, wherein the at least partially threaded support member is threaded through the thumb wheel, and a rear aiming point member adjustably coupled with the at least partially threaded support member.

Abstract: A rear sight assembly is disclosed. The rear sight assembly contains a housing defining a first opening, a second opening, and a third opening, a rear sight mechanism containing a thumb wheel positioned in the first opening, at least partially threaded support member positioned in the second opening and the third opening, wherein the at least partially threaded support member is threaded through the thumb wheel, and a rear aiming point member adjustably coupled with the at least partially threaded support member.

Abstract: A rear sight assembly is disclosed. The rear sight assembly contains a housing defining a first opening, a second opening, and a third opening, a rear sight mechanism containing a thumb wheel positioned in the first opening, at least partially threaded support member positioned in the second opening and the third opening, wherein the at least partially threaded support member is threaded through the thumb wheel, and a rear aiming point member adjustably coupled with the at least partially threaded support member.

Abstract: Systems and methods are provided for evaluating composition of a first file representing a document to be evaluated. An evaluation method transforms the first file to a second file. The second file includes a plurality of objects corresponding to the composition of the first file. The evaluation method also determines parameters based on the plurality of objects; evaluates the parameters based on a plurality of composition rules provided by a rule engine; generates evaluation findings and stores the evaluation findings; and generates an evaluation conclusion based on the evaluation findings. The evaluation conclusion indicates compliance of the document according to the composition rules.

Abstract: The invention provides isolated anti-Lp-PLA2 antibodies that bind to Lp-PLA2. The invention also encompasses compositions comprising an anti-Lp-PLA2 antibody. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Lp-PLA2 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Lp-PLA2 antibodies. The invention encompasses a method of producing the anti-Lp-PLA2 antibodies. Other aspects of the invention are a method of detecting an Lp-PLA2 in a subject.

Abstract: The invention provides isolated anti-Lp-PLA2 antibodies that bind to Lp-PLA2. The invention also encompasses compositions comprising an anti-Lp-PLA2 antibody. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Lp-PLA2 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Lp-PLA2 antibodies. The invention encompasses a method of producing the anti-Lp-PLA2 antibodies. Other aspects of the invention are a method of detecting an Lp-PLA2 in a subject.

Abstract: The invention provides isolated anti-Lp-PLA2 antibodies that bind to Lp-PLA2. The invention also encompasses compositions comprising an anti-Lp-PLA2 antibody. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Lp-PLA2 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Lp-PLA2 antibodies. The invention encompasses a method of producing the anti-Lp-PLA2 antibodies. Other aspects of the invention are a method of detecting an Lp-PLA2 in a subject.

Abstract: The invention provides isolated anti-Lp-PLA2 antibodies that bind to Lp-PLA2. The invention also encompasses compositions comprising an anti-Lp-PLA2 antibody. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Lp-PLA2 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Lp-PLA2 antibodies. The invention encompasses a method of producing the anti-Lp-PLA2 antibodies. Other aspects of the invention are a method of detecting an Lp-PLA2 in a subject.

Abstract: Systems and methods are provided for evaluating composition of a first file representing a document to be evaluated. An evaluation method transforms the first file to a second file. The second file includes a plurality of objects corresponding to the composition of the first file. The evaluation method also determines parameters based on the plurality of objects; evaluates the parameters based on a plurality of composition rules provided by a rule engine; generates evaluation findings and stores the evaluation findings; and generates an evaluation conclusion based on the evaluation findings. The evaluation conclusion indicates compliance of the document according to the composition rules.

Abstract: Various embodiments for switching programs streams using a fixed speed program stream buffer coupled to a decoder are described. Various embodiments for switching programs streams using a fixed speed program stream buffer coupled to a decoder are described. In one or more embodiments, the fixed speed program stream buffer may be arranged to receive multiple program streams, such as video program streams, and to buffer historical frames comprising at least one anchor frame. Upon detecting a channel switch point, the most recent historical anchor frame prior to the channel switch point may be provided to the decoder. After receiving the anchor frame, the decoder may be arranged to start the next frame after the anchor frame instantly. Once the most recent historical anchor frame is played in to the decoder, the decoder may pick off the next frame after the anchor frame at a normal cadence.

Abstract: The invention provides isolated anti-Pro115 antibodies that bind to Pro115. The invention also encompasses compositions comprising an anti-Pro115 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro115 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro115 antibodies. The invention encompasses a method of producing the anti-Pro115 antibodies. Other aspects of the invention are a method of killing an Pro115-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro115 antibody and a method of alleviating or treating an Pro115-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro115 antibody to the mammal.

Abstract: An IgG1? monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.

Abstract: Various embodiments for switching programs streams using a variable speed program stream buffer coupled to a variable speed decoder are described. In one or more embodiments, the variable speed program stream buffer may be arranged to receive multiple program streams, such as video program streams, and to buffer historical frames comprising at least one anchor frame. The variable speed program stream buffer may be arranged to always comprise at least one anchor frame and may be implemented by running and/or elastic buffers corresponding to an active channel program stream and one or more alternate channel program streams. Upon detecting a channel switch point, the historical frames comprising the anchor frame up to the channel switch point may be provided to the variable speed decoder in an accelerated manner.

Abstract: The invention provides isolated anti-Pro115 antibodies that bind to Pro115. The invention also encompasses compositions comprising an anti-Pro115 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro115 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro115 antibodies. The invention encompasses a method of producing the anti-Pro115 antibodies. Other aspects of the invention are a method of killing an Pro115-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro115 antibody and a method of alleviating or treating an Pro115-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro115 antibody to the mammal.

Abstract: The invention provides isolated anti-ECM-complex antibodies that bind to ECM-complexes. The invention also encompasses compositions comprising an anti-ECM-complex antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-ECM-complex antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-ECM-complex antibodies. The invention encompasses a method of producing the anti-ECM-complex antibodies. Other aspects of the invention are a method of detecting an ECM-complex expressing cancer, a method of inhibiting growth of an ECM-complex-expressing tumor, and a method of alleviating or treating an ECM-complex-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-ECM-complex antibody to the mammal.

Abstract: An IgG1? monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.